Ligand validation:2EUK

SPH: SPHINGOSINE

SPH is a Ligand Of Interest in 2EUK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2EUK_SPH_A_301	53%	57%	0.167	0.937	0.83	0.84	1	-	0	2	95%	0.9524
2EVD_SPH_A_301	56%	68%	0.162	0.944	0.6	0.64	-	-	0	2	95%	0.9524
2EUM_SPH_A_301	51%	67%	0.166	0.928	0.62	0.64	1	-	0	2	95%	0.9524
1SX6_SPH_A_301	43%	55%	0.153	0.883	1.02	0.73	1	-	1	2	95%	0.9524
2EVL_SPH_A_301	43%	67%	0.189	0.92	0.43	0.84	-	-	0	2	95%	0.9524
5OSN_SPH_A_301	92%	61%	0.081	0.973	0.66	0.82	1	1	2	0	100%	1
3VBF_SPH_A_301	50%	55%	0.201	0.953	0.93	0.81	1	1	3	0	100%	1
3VBH_SPH_A_301	48%	64%	0.189	0.934	0.65	0.74	-	1	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.